Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul 31:8:F1000 Faculty Rev-1279.
doi: 10.12688/f1000research.19197.1. eCollection 2019.

Recent advances in understanding dengue

Affiliations
Review

Recent advances in understanding dengue

Scott Halstead. F1000Res. .

Abstract

This is a selective review of recent publications on dengue clinical features, epidemiology, pathogenesis, and vaccine development placed in a context of observations made over the past half century. Four dengue viruses (DENVs) are transmitted by urban cycle mosquitoes causing diseases whose nature and severity are influenced by interacting factors such as virus, age, immune status of the host, and human genetic variability. A phenomenon that controls the kinetics of DENV infection, antibody-dependent enhancement, best explains the correlation of the vascular permeability syndrome with second heterotypic DENV infections and infection in the presence of passively acquired antibodies. Based on growing evidence in vivo and in vitro, the tissue-damaging DENV non-structural protein 1 (NS1) is responsible for most of the pathophysiological features of severe dengue. This review considers the contribution of hemophagocytic histiocytosis syndrome to cases of severe dengue, the role of movement of humans in dengue epidemiology, and modeling and planning control programs and describes a country-wide survey for dengue infections in Bangladesh and efforts to learn what controls the clinical outcome of dengue infections. Progress and problems with three tetravalent live-attenuated vaccines are reviewed. Several research mysteries remain: why is the risk of severe disease during second heterotypic DENV infection so low, why is the onset of vascular permeability correlated with defervescence, and what are the crucial components of protective immunity?

Keywords: dengue; dengue fever; epidemiology; flavivirus; immunity; pathogenesis; severe dengue; vaccines.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.

References

    1. Vasilakis N, Shell EJ, Fokam EB, et al. : Potential of ancestral sylvatic dengue-2 viruses to re-emerge. Virology. 2007;358(2):402–12. 10.1016/j.virol.2006.08.049 - DOI - PMC - PubMed
    1. Pollett S, Melendrez MC, Maljkovic Berry I, et al. : Understanding dengue virus evolution to support epidemic surveillance and counter-measure development. Infect Genet Evol. 2018;62:279–295. 10.1016/j.meegid.2018.04.032 - DOI - PMC - PubMed
    1. Powell JR, Gloria-Soria A, Kotsakiozi P: Recent History of Aedes aegypti: Vector Genomics and Epidemiology Records. BioScience. 2018;68(11):854–860. 10.1093/biosci/biy119 - DOI - PMC - PubMed
    1. Kraemer MUG, Reiner RC, Brady OJ, et al. : Past and future spread of the arbovirus vectors Aedes aegypti and Aedes albopictus. Nat Microbiol. 2019;4(5):854–863. 10.1038/s41564-019-0376-y - DOI - PMC - PubMed
    1. Chen R, Vasilakis N: Dengue--quo tu et quo vadis? Viruses. 2011;3(9):1562–608. 10.3390/v3091562 - DOI - PMC - PubMed